Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYAmarin Announced FDA Advisory Committee Voted Unanimously (16-0) to Recommend Approval of Vascepa® (icosapent ethyl) Capsules Label Expansion to Reduce Cardiovascular Risk Based on Landmark REDUCE-IT® Outcomes TrialPREV STORYSELLAS Life Sciences Provides Business Update and Reports Third Quarter 2019 Financial Results
